Aortic Intramural Hematoma: CT Diagnosis, High-Risk Imaging Features, and the Clinical Dilemma of TEVAR

When a Type B Aortic Intramural Hematoma Evolves Into Retrograde Type A Dissection

By Dr. Elias Lee | ScholarGen MediAI

Executive Answer

Aortic intramural hematoma (IMH) is an acute aortic syndrome characterized by hemorrhage within the aortic media, typically appearing on noncontrast CT as crescentic or circumferential hyperattenuating aortic wall thickening without a patent false lumen. Recognizing IMH requires careful assessment of aortic wall thickness, total aortic diameter, focal intimal disruption, ulcer-like projections, and interval progression. Although uncomplicated Stanford type B IMH may be managed initially with anti-inflammatory medical therapy and close imaging surveillance, high-risk imaging findings can justify intervention. Importantly, thoracic endovascular aortic repair (TEVAR) introduces its own risks, including retrograde type A aortic dissection.

1. Why This Case Matters

Acute aortic syndromes are among the most consequential diagnoses encountered in emergency radiology. Their clinical presentations frequently overlap with more common causes of chest pain, while the consequences of delayed recognition can be catastrophic.

Aortic intramural hematoma deserves particular attention because its initial imaging appearance may be subtle. Unlike classic aortic dissection, IMH may not demonstrate an obvious intimal flap or a clearly opacified false lumen. The diagnosis therefore depends heavily on recognizing abnormalities within the aortic wall itself.

The present case illustrates several important clinical and radiologic issues:

  • Recognition of aortic IMH on noncontrast CT.

  • Identification of focal intimal abnormalities on contrast-enhanced CT.

  • Assessment of imaging features associated with disease progression.

  • Selection between medical management and endovascular intervention.

  • Recognition of retrograde type A dissection following TEVAR.

  • The importance of longitudinal CT surveillance after aortic intervention.

The most important lesson is that aortic IMH should not be interpreted as a static collection of blood within the aortic wall. It represents an evolving disease process in which the relationship between the aortic wall, intimal integrity, and hemodynamic stress may change over time.

For the radiologist, the diagnostic task extends beyond identifying the hematoma. It includes determining whether the aortic wall demonstrates features suggesting instability and communicating those findings in a clinically actionable manner.

2. Clinical Presentation: Acute Chest Pain in a 62-Year-Old Woman

A 62-year-old woman presented with chest pain. Her clinical condition and hemodynamic status remained stable with minimal nitroglycerin infusion.

An initial noncontrast CT examination was performed.

At the level of the origin of the left pulmonary artery, axial images demonstrated an approximately 1-cm-thick crescent-shaped area of hyperattenuation measuring approximately 60 Hounsfield units (HU) within the lateral wall of the descending thoracic aorta.

This finding immediately raises concern for acute aortic wall hemorrhage.

The combination of acute chest pain and crescentic hyperattenuating aortic wall thickening is highly suggestive of aortic intramural hematoma.

The absence of an obvious intimal flap does not exclude an acute aortic syndrome. In fact, the lack of a patent false lumen is one of the defining imaging characteristics that helps distinguish IMH from classic aortic dissection.

The patient's initial hemodynamic stability should not be interpreted as evidence of a benign aortic condition. Clinical stability and morphologic stability are different concepts.

A patient may appear clinically stable while CT demonstrates focal intimal disruption or other features associated with potential progression.

3. CT Diagnosis of Aortic Intramural Hematoma

3.1 The importance of noncontrast CT

Figure 1. Noncontrast axial CT. 

Caption: Crescentic hyperattenuating wall thickening in the descending thoracic aorta, approximately 60 HU.

Noncontrast CT is a particularly important component of the imaging evaluation of suspected acute aortic syndrome.

In aortic IMH, the characteristic finding is increased attenuation within the aortic wall before contrast administration.

The hemorrhage within the media produces a hyperattenuating crescentic or circumferential region of wall thickening.

Typical findings include:

  • Crescentic or circumferential aortic wall thickening.

  • Increased attenuation on noncontrast CT.

  • Absence of a clearly visible intimal flap.

  • Absence of a patent false lumen.

  • Possible displacement of pre-existing intimal calcification toward the aortic lumen.

The reported attenuation in this patient was approximately 60 HU, consistent with acute blood within the aortic wall.

The morphology is equally important. A crescentic abnormality involving the aortic wall is more characteristic of IMH than an isolated intraluminal filling defect.

Atherosclerotic calcification generally has much higher attenuation and follows the expected distribution of the intimal plaque. Displaced intimal calcification may provide an additional clue to underlying aortic wall pathology.

3.2 Why contrast-enhanced CT is also necessary

Figure 2. Contrast-enhanced axial CT

Caption: Focal intimal abnormalities at two levels of the aorta.


Figure 3. Contrast-enhanced coronal CT

Caption: Longitudinal extent of aortic wall involvement from the left subclavian artery toward the celiac artery.

After the initial noncontrast examination, contrast-enhanced CT provides additional information about the extent of the disease and the integrity of the aortic lumen.

In this case, axial contrast-enhanced CT demonstrated focal intimal abnormalities at the level of the pulmonary artery bifurcation and the upper abdomen.

These abnormalities were described as entry and distal intimal disruptions, with concern for progression toward aortic dissection or rupture.

The coronal images demonstrated longitudinal extension of the abnormal aortic wall from the region of the left subclavian artery toward the celiac artery.

This finding is important because aortic IMH is a longitudinal disease process. Evaluation of a single axial image cannot establish the complete extent of the abnormality.

A complete assessment should include:

  1. The proximal extent of the hematoma.

  2. The distal extent of the hematoma.

  3. Maximum aortic diameter.

  4. Maximum hematoma thickness.

  5. Presence and location of focal intimal disruption.

  6. Ulcer-like projections.

  7. Periaortic hemorrhage or inflammatory change.

  8. Pleural or pericardial effusion.

  9. Evidence of branch-vessel compromise.

  10. Interval changes compared with previous examinations.

The distinction between IMH and classic dissection remains essential. A focal intimal disruption may coexist with IMH, but the presence of such a disruption does not automatically establish a classic dissection with a patent false lumen.

The radiologist must describe the actual morphology rather than relying exclusively on a diagnostic label.

3.3 Multiplanar CT interpretation

Coronal and sagittal reconstructions are particularly valuable when assessing the longitudinal distribution of aortic IMH.

In the present case, the coronal CT image demonstrated extensive aortic wall involvement extending from the left subclavian artery toward the celiac artery.

This information is clinically important for both risk assessment and procedural planning.

A useful CT interpretation should describe not only the presence of IMH but also its relationship to the aortic arch, major branch vessels, and potential proximal and distal landing zones for endovascular repair.

4. Stanford Classification: Why This Is Type B IMH

Aortic intramural hematoma is classified using the same anatomic principles applied to classic aortic dissection.

Stanford type A IMH involves the ascending aorta, regardless of the location of the primary abnormality.

Stanford type B IMH is confined to the descending thoracic aorta and does not involve the ascending aorta.

The initial diagnosis in this patient was Stanford type B aortic intramural hematoma.

This distinction is critical because management differs substantially according to the anatomic classification.

Type A IMH generally requires urgent surgical evaluation because of the potential for cardiac tamponade, aortic rupture, aortic regurgitation, and other life-threatening complications.

Type B IMH is more frequently managed initially with intensive medical therapy and imaging surveillance when uncomplicated.

However, type B IMH should never be considered automatically low risk. High-risk morphologic features, persistent symptoms, aortic enlargement, or evidence of progression may justify endovascular or surgical treatment.

5. Differential Diagnosis: Conditions That Mimic Aortic IMH

Correct identification requires differentiation from several important aortic abnormalities.

Figure 4. Additional CT example

Caption: Additional example illustrating the appearance of aortic intramural hematoma.

5.1 Classic aortic dissection

Classic aortic dissection is characterized by an intimal flap separating the true and false lumens.

Contrast-enhanced CT usually demonstrates differential enhancement of the two lumens, although the appearance varies with flow dynamics and the degree of false-lumen thrombosis.

In contrast, uncomplicated IMH typically demonstrates crescentic or circumferential aortic wall thickening without a patent false lumen.

A thrombosed false lumen may resemble IMH. The presence of an intimal flap, displaced calcification, and the overall configuration of the aortic wall should therefore be carefully evaluated.

5.2 Penetrating atherosclerotic ulcer

A penetrating atherosclerotic ulcer (PAU) develops when an atherosclerotic plaque ulcerates through the internal elastic lamina and penetrates into the aortic media.

On contrast-enhanced CT, PAU typically appears as a focal contrast-filled outpouching extending beyond the expected contour of the aortic lumen.

PAU may coexist with IMH and is clinically important because it can indicate increased risk of progression and aortic complications.

The distinction between PAU and focal intimal disruption in IMH requires attention to the presence of underlying atherosclerotic plaque and the morphology of the contrast-filled abnormality.

5.3 Aortitis

Aortitis may produce aortic wall thickening and enhancement.

However, inflammatory aortic disease more commonly produces relatively diffuse or circumferential wall abnormalities, sometimes accompanied by periaortic inflammatory change.

Clinical context, laboratory findings, vascular distribution, and, when appropriate, metabolic imaging can help establish the diagnosis.

The absence of a focal intimal disruption or intramural blood collection may favor an inflammatory process over acute IMH, although imaging appearances can overlap.

5.4 Incomplete aortic dissection

Incomplete dissection may produce an abnormal aortic wall without the typical configuration of a fully developed false lumen.

The distinction depends on whether there is actual separation of the medial layers, a visible intimal flap, or another demonstrable dissection plane.

In difficult cases, comparison of noncontrast CT, arterial-phase CTA, and follow-up examinations can be particularly helpful.

6. Imaging Biomarkers and Prognostic Assessment

The diagnostic value of CT extends beyond identifying aortic IMH.

Morphologic measurements help stratify the risk of disease progression and guide decisions regarding surveillance and intervention.

6.1 Maximum hematoma thickness

Maximum hematoma thickness is an important prognostic measurement.

The original case demonstrated approximately 1 cm of aortic wall thickening.

However, this measurement should not be interpreted in isolation.

The 2022 ACC/AHA Guideline identifies hematoma thickness of at least 13 mm as a high-risk imaging feature in type B IMH.

The guideline also identifies other important findings, including a maximum aortic diameter greater than approximately 47–50 mm and acute-phase focal intimal disruption with an ulcer-like projection in the descending thoracic aorta.

These thresholds are risk-stratification criteria, not absolute boundaries separating safe from dangerous disease.

6.2 Maximum aortic diameter

Maximum aortic diameter should be measured consistently using appropriate multiplanar reconstructions.

An increase in aortic diameter on serial imaging may indicate progression even when the patient remains clinically stable.

Measurements should be performed perpendicular to the aortic centerline whenever possible to avoid overestimation caused by oblique imaging planes.

6.3 Focal intimal disruption and ulcer-like projection

Focal intimal disruption (FID) is particularly important in the evaluation of type B IMH.

The 2022 ACC/AHA guideline distinguishes focal intimal disruption from tiny intimal disruption using the communicating orifice size, with a threshold greater than 3 mm for FID.

Acute-phase focal intimal disruption with an ulcer-like projection is associated with increased risk.

These abnormalities should be evaluated in relation to:

  • Their location.

  • The size of the communicating orifice.

  • Their depth and morphology.

  • Their appearance on serial examinations.

  • Associated aortic enlargement.

  • Changes in hematoma thickness.

The presence of an intimal abnormality should prompt careful assessment, but the terminology must remain precise. A focal intimal disruption is not automatically equivalent to a large entry tear of classic aortic dissection.

6.4 Additional high-risk findings

Other findings that deserve attention include:

  • Increasing or recurrent pleural effusion.

  • Periaortic hematoma.

  • Increasing aortic diameter.

  • Increasing hematoma thickness.

  • Progression to aortic dissection.

  • Persistent or recurrent chest or back pain.

  • Malperfusion.

  • Evidence of impending or established rupture.

Aortic IMH should therefore be assessed using a combination of clinical and imaging parameters rather than a single numerical measurement.

7. Management of Type B Aortic Intramural Hematoma

The treatment strategy for type B IMH is determined by clinical stability, imaging morphology, aortic anatomy, and the presence of complications.

7.1 Initial medical management

For uncomplicated type B IMH, initial management generally includes intensive blood pressure control, heart-rate control, analgesia, and close clinical monitoring.

The central objective is to reduce aortic wall stress.

Anti-impulse therapy commonly uses intravenous beta-blockers as first-line treatment when appropriate. Additional vasodilator therapy may be considered when blood pressure remains elevated after adequate heart-rate control.

The 2022 ACC/AHA guideline recommends reducing systolic blood pressure to below 120 mmHg, or to the lowest level that maintains adequate end-organ perfusion, together with heart-rate control.

The patient's clinical condition must be monitored continuously because excessive reduction in blood pressure can compromise organ perfusion.

7.2 When should intervention be considered?

Medical treatment alone may be appropriate in uncomplicated type B IMH.

However, intervention should be considered when there is evidence of:

  • Aortic rupture or impending rupture.

  • Persistent or recurrent pain despite appropriate treatment.

  • Malperfusion.

  • Progressive aortic enlargement.

  • Increasing hematoma thickness.

  • Acute-phase focal intimal disruption with ulcer-like projection.

  • High-risk aortic dimensions.

  • Increasing pleural effusion.

The 2022 ACC/AHA guideline states that intervention may be reasonable in otherwise uncomplicated type B IMH when high-risk imaging features are present.

The 2024 ESC Guidelines similarly recommend initial medical therapy with careful surveillance for type B IMH, TEVAR for complicated disease, and consideration of TEVAR in uncomplicated cases with high-risk imaging features.

The important distinction is between a recommendation for intervention in complicated disease and an individualized decision to intervene in a patient who is clinically stable but demonstrates concerning imaging morphology.

7.3 The role of TEVAR


Figure 5. DSA

Caption: Endovascular stent-graft placement for type B IMH.

Thoracic endovascular aortic repair has become an important treatment option for selected patients with complicated type B IMH.

The procedure aims to exclude the principal intimal entry site, reduce abnormal aortic wall stress, promote favorable remodeling, and prevent progression to rupture or dissection.

However, the success of TEVAR depends on more than the technical deployment of a stent graft.

Preprocedural evaluation should include:

  • Proximal and distal landing-zone assessment.

  • Aortic diameter measurements.

  • Aortic curvature and tortuosity.

  • Branch-vessel anatomy.

  • Left subclavian artery involvement.

  • Iliac and femoral access anatomy.

  • Potential spinal cord ischemia risk.

  • Appropriate device sizing.

A sufficient landing zone is essential to reduce the risk of endoleak and device migration.

The amount of stent-graft oversizing also requires careful consideration. Excessive radial force in a fragile aortic wall may contribute to complications.

The ACC/AHA guideline notes that TEVAR sizing generally avoids excessive oversizing, usually not exceeding approximately 10%, and recommends avoiding balloon aortoplasty at the landing zones in this setting.

8. The Critical Event: Retrograde Type A Aortic Dissection After TEVAR

Figure 6. Follow-up CTA

Caption: Retrograde type A aortic dissection following TEVAR.

In the present case, the patient underwent TEVAR using a Medtronic Valiant Navion stent graft measuring 34 × 174 mm.

The free-flow portion was positioned at the origin of the left subclavian artery.

The intervention was intended to stabilize the descending thoracic aortic pathology.

However, the subsequent clinical course demonstrated an important complication.

Four weeks after TEVAR, follow-up CT revealed retrograde type A aortic dissection extending into the ascending aorta and reaching the origin of the right coronary artery.

This was a major change in the patient's aortic disease classification.

The original type B process had now been complicated by involvement of the ascending aorta, creating a life-threatening condition.

8.1 Why can retrograde type A dissection occur?

Retrograde type A dissection is a recognized complication following TEVAR.

Several mechanisms have been proposed:

  1. Mechanical interaction between the proximal stent-graft edge and the aortic wall.

  2. Excessive radial force at the proximal landing zone.

  3. Excessive stent-graft oversizing.

  4. Aortic wall fragility associated with the underlying acute aortic syndrome.

  5. Adverse effects of aortic curvature and device configuration.

  6. Proximal landing-zone injury or previously unrecognized intimal abnormalities.

These mechanisms are not mutually exclusive.

In a patient with IMH, the aortic media is already structurally compromised. Additional mechanical stress may therefore have clinically important consequences.

8.2 A critical review of device sizing in this case

One detail deserves particular attention.

The reported stent-graft diameter was 34 mm, while the aortic diameter immediately distal to the left subclavian artery was reported as approximately 29 mm.

If these measurements represent comparable sizing dimensions obtained at the same anatomical level, the nominal diameter difference corresponds to approximately 17% oversizing.

This is a calculated comparison, not proof that the device was incorrectly selected.

Accurate device-sizing assessment requires review of the original centerline measurements, the actual proximal landing-zone diameter, the manufacturer's sizing recommendations, the device's configuration, and the relevant aortic anatomy.

Nevertheless, the comparison raises an important question about the relationship between device oversizing, radial force, and aortic wall injury.

In a diseased aorta, the smallest technically acceptable degree of oversizing should be considered in the context of secure fixation and the risk of proximal aortic injury.

The objective is not simply to achieve a tight seal. It is to achieve a durable repair without imposing unnecessary mechanical stress on an already vulnerable aortic wall.

8.3 Why follow-up CT is essential

The development of retrograde type A dissection demonstrates why technical success at the time of TEVAR does not establish long-term procedural safety.

Follow-up imaging should assess:

  • Proximal stent-graft integrity.

  • The relationship between the graft and the aortic wall.

  • New intimal injury.

  • Retrograde dissection.

  • Endoleak.

  • Graft migration.

  • Aortic remodeling.

  • Changes in the residual hematoma.

  • Branch-vessel perfusion.

New chest pain, hemodynamic deterioration, or unexplained clinical changes after TEVAR should prompt urgent reassessment.

9. Surgical Management After Retrograde Type A Dissection

Following the detection of retrograde type A dissection, the patient underwent open surgical treatment.

The ascending aorta was replaced with a 28-mm Dacron tube graft (Maquet Hemashield), while the arch and descending thoracic aortic segment were replaced using a Thoraflex 30/34 Hybrid Plexus prosthesis (Vascutek).

Four weeks after surgery, contrast-enhanced CT demonstrated no reported complications.

This treatment sequence illustrates an important principle in acute aortic disease.

Once the ascending aorta becomes involved in an acute dissection, the clinical priorities change substantially.

The treatment strategy must address the immediate risk of rupture, cardiac tamponade, coronary involvement, and other complications associated with type A disease.

In this patient, open surgical repair was performed after the endovascular complication.

The subsequent CT examination provided an important assessment of the reconstructed aorta and the postoperative result.

10. The Management Dilemma: Should TEVAR Have Been Performed Earlier?

This is arguably the most important clinical question raised by the case.

The patient initially had type B IMH and remained hemodynamically stable. The reported hematoma burden was relatively limited, but focal intimal abnormalities and interval imaging concerns raised the possibility of disease instability.

Was immediate TEVAR the most appropriate approach?

Could continued medical therapy and close CT surveillance have been safer?

Or should an alternative surgical strategy have been considered?

These questions cannot be answered retrospectively by looking only at the subsequent complication.

The development of retrograde type A dissection does not automatically establish that the initial decision to perform TEVAR was inappropriate.

Similarly, a technically successful initial procedure does not prove that the intervention was the optimal strategy.

A balanced assessment requires consideration of the competing risks.

Scenario A: Continued medical management

If the patient had no persistent pain, no malperfusion, no rupture, and no convincing progression, intensive anti-impulse medical therapy with early repeat imaging could have been considered.

This strategy avoids immediate endovascular manipulation of a vulnerable aortic wall.

However, it carries the risk of continued hematoma progression, development of focal intimal disruption, dissection, or rupture.

Scenario B: Early TEVAR

If serial imaging demonstrated progressive focal intimal disruption, increasing aortic dimensions, or other high-risk changes, intervention could be justified despite initial clinical stability.

TEVAR may prevent further progression in appropriately selected patients.

However, the procedure introduces risks associated with access, landing zones, device sizing, branch-vessel coverage, and retrograde dissection.

Scenario C: Open or alternative hybrid repair

Open surgical repair may be appropriate when endovascular anatomy is unfavorable or when the diseased segment extends into a region where secure proximal sealing cannot be achieved without unacceptable risk.

The choice between TEVAR, open surgery, and hybrid treatment requires multidisciplinary assessment by cardiovascular surgeons, vascular specialists, interventional radiologists, and diagnostic radiologists.

The central lesson is that treatment should be based on the overall risk profile, not on a single CT measurement or the mere presence of IMH.

11. The Role of MRI in Aortic IMH

CT remains the principal imaging modality in the acute evaluation of suspected aortic IMH because of its speed, availability, spatial resolution, and ability to evaluate the entire aorta.

MRI can provide complementary information, particularly in patients requiring repeated imaging or when additional characterization of the aortic wall is needed.

Potential MRI approaches include:

  • T1-weighted imaging.

  • T2-weighted imaging.

  • Black-blood imaging.

  • Three-dimensional fast spin-echo techniques.

  • Noncontrast MR angiography.

  • Contrast-enhanced MR angiography.

MRI can help distinguish intramural blood products from atherosclerotic wall thickening and other aortic abnormalities.

However, MRI is not always practical in unstable patients or when rapid exclusion of an acute aortic catastrophe is required.

The choice of imaging modality should reflect the clinical urgency, patient stability, renal function, contrast considerations, and the specific diagnostic question.

12. Diagnostic Workflow: From Emergency CT to Definitive Management

A structured imaging workflow can improve the recognition and communication of acute aortic disease.

Step 1: Initial noncontrast CT

Look for crescentic or circumferential hyperattenuating aortic wall thickening.

Assess attenuation, wall thickness, displaced calcification, and the presence of intramural blood.

Step 2: Contrast-enhanced CTA

Evaluate the aortic lumen, intimal integrity, focal intimal disruption, ulcer-like projections, and possible false-lumen formation.

Step 3: Whole-aorta assessment

Review the aortic root, ascending aorta, arch, descending thoracic aorta, abdominal aorta, and major branch vessels.

Step 4: Risk stratification

Measure maximum aortic diameter and hematoma thickness. Identify focal intimal abnormalities, pleural effusion, periaortic hematoma, and evidence of progression.

Step 5: Clinical correlation

Integrate imaging findings with pain severity, blood pressure, heart rate, organ perfusion, and other relevant clinical parameters.

Step 6: Multidisciplinary decision

Determine whether the patient requires medical treatment alone, TEVAR, open surgical repair, or a hybrid approach.

Step 7: Follow-up imaging

Establish a surveillance strategy based on the initial disease severity, intervention, and subsequent imaging findings.

The radiologist's report should communicate the presence of high-risk features directly rather than leaving the treating team to infer their significance from a descriptive paragraph.

13. Artificial Intelligence in Aortic Imaging: A Second-Reader Opportunity

Aortic IMH represents an interesting application for medical imaging AI because the diagnostic findings are often subtle, distributed across multiple CT slices, and dependent on comparison between noncontrast and contrast-enhanced examinations.

Potential AI applications include:

Automated aortic segmentation

AI-assisted segmentation could provide reproducible measurements of aortic diameter, wall thickness, and longitudinal disease extent.

Abnormal wall attenuation detection

Computer vision models could help identify crescentic hyperattenuating regions on noncontrast CT.

Focal intimal disruption detection

AI systems may assist in identifying small contrast-filled outpouchings or focal intimal abnormalities that deserve closer review.

Longitudinal imaging comparison

Automated comparison of serial CTA examinations could highlight changes in hematoma thickness, aortic diameter, and the appearance of new intimal abnormalities.

Post-TEVAR complication surveillance

AI-assisted image analysis could potentially support detection of endoleaks, graft migration, new dissection flaps, and changes in the proximal landing zone.

However, these applications should be understood as potential technological opportunities rather than established diagnostic capabilities for every commercial AI platform.

13.1 Important limitations of AI

AI systems may fail when:

  • The aortic wall abnormality is subtle.

  • Motion artifacts affect the aortic root.

  • Contrast timing is inadequate.

  • Calcified atherosclerotic plaques mimic wall abnormalities.

  • The training dataset contains insufficient examples of IMH.

  • The system encounters unfamiliar stent-graft configurations.

  • Prior imaging is unavailable for comparison.

False-positive findings can create unnecessary alerts, while false-negative results may provide inappropriate reassurance.

The most useful role for AI is therefore as a second reader and quantitative support tool.

Final interpretation must remain under the responsibility of qualified clinicians.

14. Diagnostic Risk and Healthcare Workflow Implications

Aortic IMH demonstrates why emergency radiology requires a systematic approach to the entire examination.

A patient presenting with chest pain may initially be evaluated for pulmonary embolism, acute coronary syndrome, or other thoracic abnormalities.

However, aortic pathology can be overlooked if the interpretation is restricted to the original clinical question.

A dedicated review of the aortic wall, particularly on noncontrast images, can reveal findings that fundamentally change the clinical diagnosis.

The most important workflow vulnerabilities include:

  • Failure to review noncontrast images.

  • Incomplete assessment of the descending thoracic aorta.

  • Failure to recognize subtle focal intimal disruption.

  • Inadequate comparison with previous examinations.

  • Incomplete communication of high-risk findings.

  • Lack of structured post-intervention surveillance.

From a healthcare-system perspective, early recognition and appropriate risk stratification may reduce avoidable diagnostic delays and improve coordination between emergency physicians, radiologists, and cardiovascular specialists.

AI-supported workflow tools may eventually help standardize aortic measurements and identify examinations requiring urgent review.

Nevertheless, the value of such systems should be established through independent clinical validation, workflow assessment, and continuous quality monitoring.

15. Practical Radiology Pearls

  1. Always review noncontrast CT images. Crescentic hyperattenuating aortic wall thickening is a key clue to IMH.

  2. Do not require an intimal flap to diagnose IMH. A patent false lumen is not necessary for the diagnosis.

  3. Measure the maximum hematoma thickness. It contributes to prognostic assessment.

  4. Measure the maximum aortic diameter perpendicular to the centerline. Avoid oblique measurements that may overestimate the diameter.

  5. Look for focal intimal disruption and ulcer-like projections. Their presence, morphology, and timing are clinically important.

  6. Evaluate the entire aorta. The proximal and distal extent of IMH must be established.

  7. Assess pleural and pericardial effusions. New or increasing effusions may indicate a more complicated clinical course.

  8. Do not equate hemodynamic stability with low imaging risk. Clinical and morphologic assessments must be integrated.

  9. Consider device sizing carefully before TEVAR. Excessive oversizing and unnecessary radial stress may be harmful in a vulnerable aorta.

  10. Never assume that technical success guarantees procedural safety. Retrograde type A dissection can occur after TEVAR.

  11. Maintain close imaging surveillance. Disease progression and postprocedural complications may develop after an initially reassuring examination.

  12. Communicate high-risk findings immediately. Aortic IMH is a condition in which timely multidisciplinary decision-making is essential.

16. Frequently Asked Questions

What is the characteristic CT finding of aortic intramural hematoma?

The characteristic finding is crescentic or circumferential hyperattenuating aortic wall thickening on noncontrast CT, usually without a visible intimal flap or patent false lumen.

Why is noncontrast CT important in diagnosing IMH?

Noncontrast CT demonstrates the increased attenuation of acute blood within the aortic media. Contrast-enhanced CT alone may make this finding more difficult to distinguish from other aortic wall abnormalities.

What distinguishes type A from type B aortic IMH?

Type A involves the ascending aorta, whereas type B is confined to the descending thoracic aorta without ascending aortic involvement.

When should type B IMH be treated with TEVAR?

TEVAR is recommended for complicated type B IMH in appropriate anatomical circumstances. It should also be considered in selected otherwise uncomplicated patients with high-risk imaging features, following individualized assessment.

What is retrograde type A dissection after TEVAR?

It is a complication in which dissection extends proximally into the ascending aorta after an endovascular procedure performed for descending aortic disease.

Can AI detect aortic intramural hematoma?

AI may assist with aortic segmentation, wall attenuation analysis, detection of focal abnormalities, and comparison of serial CT examinations. However, its diagnostic performance for these specific tasks must be independently validated.

17. Final Clinical Perspective

Aortic intramural hematoma is a diagnosis in which the quality of CT interpretation can directly influence treatment strategy.

The crescentic hyperattenuating aortic wall on noncontrast CT is a relatively straightforward finding when recognized. The more difficult task is determining whether the abnormality represents stable disease or an evolving acute aortic syndrome with a meaningful risk of progression.

This case highlights the complexity of that decision.

The patient initially presented with type B IMH and underwent TEVAR because of concerning aortic morphology. Four weeks later, retrograde type A dissection developed, requiring extensive open surgical reconstruction.

The case should not be interpreted as evidence that TEVAR is inappropriate for type B IMH. Rather, it underscores the importance of individualized risk assessment, careful device selection, precise anatomical planning, and continued post-intervention surveillance.

In modern aortic imaging, the radiologist's responsibility extends beyond identifying the hematoma.

It includes recognizing features that suggest instability, understanding the potential consequences of intervention, and providing information to support a coordinated multidisciplinary treatment strategy.

The most important principle is simple:

In aortic intramural hematoma, the diagnosis identifies the disease, but the morphology, temporal evolution, and clinical context determine the risk.

Internal linking architecture



References

  1. Ferrera C, Vilacosta I, Cabeza B, et al. Diagnosing aortic intramural hematoma: current perspectives. Vascular Health and Risk Management. 2020;16:203–213. https://doi.org/10.2147/VHRM.S193967

  2. Sahu KK, Lal A, Mishra AK. Additional insights regarding aortic intramural hematoma. Canadian Journal of Anesthesia. 2020;67:382–383. https://doi.org/10.1007/s12630-019-01490-w

  3. Mendoza D, Terpenning S, Verma S, et al. Retrospective comparative analysis of computed tomography findings of acute and chronic aortic dissections and intramural hematomas. Journal of Thoracic Imaging. 2019;34:400–403. https://doi.org/10.1097/RTI.0000000000000401

  4. Li Z, Liu C, Wu R, et al. Prognostic value of clinical and morphologic findings in patients with type B aortic intramural hematoma. Journal of Cardiothoracic Surgery. 2020;15:49. https://doi.org/10.1186/s13019-020-1067-8

  5. Nation DA, Wang GJ. TEVAR: endovascular repair of the thoracic aorta. Seminars in Interventional Radiology. 2015;32:265–271. https://doi.org/10.1055/s-0035-1558824

  6. Mesar T, Lin MJ, Kabir I, et al. Medical therapy in type B aortic intramural hematoma is associated with a high failure rate. Journal of Vascular Surgery. 2020;71:1088–1096. https://doi.org/10.1016/j.jvs.2019.07.084

  7. Filippone G, La Barbera G, Valentino F, et al. Conservative management of uncomplicated acute type B intramural hematoma of the aorta is not always the right solution. Annals of Vascular Surgery. 2019;61(Suppl):469.e5–469.e11. https://doi.org/10.1016/j.avsg.2019.05.022

  8. Li Z, Lu B, Chen Y, et al. Acute type B aortic intramural hematoma: the added prognostic value of a follow-up CT. European Radiology. 2019;29:6571–6580. https://doi.org/10.1007/s00330-019-06254-0

  9. Tanaka A, Leake S, Estrera AL. Management strategies in acute type B aortic intramural hematoma. Current Opinion in Cardiology. 2017;32:687–691. https://doi.org/10.1097/HCO.0000000000000453

  10. Isselbacher EM, Preventza O, Hamilton Black J III, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease. Circulation. 2022;146:e334–e482. https://doi.org/10.1161/CIR.0000000000001106

  11. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. European Heart Journal. 2024;45:3538–3700. https://doi.org/10.1093/eurheartj/ehae179


Author: Dr. Elias Lee
ScholarGen MediAI | Medical Imaging, Clinical AI & Healthcare Technology

Copyright © 2026 ScholarGen Inc. All rights reserved.

This article is intended for professional medical education and should not replace individualized clinical judgment or institutional treatment protocols.

Comments

Popular posts from this blog

Understanding Tubal Ligation Clips: Imaging, Risks, Migration, and Management

Teres Minor Atrophy: Causes, Imaging, and Clinical Implications

The Lethal Lens: Mastering the Diagnosis and Management of Epidural Hemorrhage (EDH)